相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis
Suxing Liu et al.
SCIENTIFIC REPORTS (2021)
Agonist Lock Touched and Untouched Retinoic Acid Receptor-Related Orphan Receptor-γt (RORγt) Inverse Agonists: Classification Based on the Molecular Mechanisms of Action
Nannan Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
Xiaohua Xue et al.
SCIENTIFIC REPORTS (2021)
(Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease
Anton M. Jetten et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Discovery of N-indanyl benzamides as potent RORγt inverse agonists
Jinlong Tian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
David A. Carcache et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
Vrajesh B. Pandya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of (&ITcis&IT-3-({(5&ITR&IT)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1&ITH&IT-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5&ITH&IT)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist
Mitsunori Kono et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design
Frank Narjes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345
Christian Gege
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Structural States of RORgt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds
Joerg Kallen et al.
CHEMMEDCHEM (2017)
Interleukin 17 is a chief orchestrator of immunity
Marc Veldhoen
NATURE IMMUNOLOGY (2017)
SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious ROR gamma Inhibitor
Kazuyuki Hirata et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742
Christian Gege
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
Benjamin Farahnik et al.
DERMATOLOGY AND THERAPY (2016)
Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist
Benjamin P. Fauber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Christopher E. M. Griffiths et al.
LANCET (2015)
The IL-23-IL-17 axis in inflammatory arthritis
Erik Lubberts
NATURE REVIEWS RHEUMATOLOGY (2015)
Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
Satoshi Okada et al.
SCIENCE (2015)
Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
Yonghui Wang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Identification of an allosteric binding site for RORγt inhibition
Marcel Scheepstra et al.
NATURE COMMUNICATIONS (2015)
Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
Benjamin P. Fauber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling
Khalifa El Malki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORλt Protein
Tao Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
Laura A. Solt et al.
NATURE (2011)
The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse Agonist
Naresh Kumar et al.
MOLECULAR PHARMACOLOGY (2010)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties
P Ertl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
